|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
13,870,000 |
Market
Cap: |
450.64(M) |
Last
Volume: |
90,444 |
Avg
Vol: |
64,972 |
52
Week Range: |
$17.67 - $38.49 |
|
Level
I Sector: |
Basic Materials |
Level
II Sector: |
Chemicals |
Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,872 |
Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Olson Charles W |
SVP, Medical Device Coatings |
|
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,535 |
46,096 |
|
- |
|
Olson Charles W |
SVP, Medical Device Coatings |
|
2022-11-30 |
4 |
D |
$36.13 |
$48,486 |
D/D |
(1,342) |
40,561 |
|
- |
|
Sides Teri Woodwick |
SVP, Vascular Interventions |
|
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,303 |
28,017 |
|
- |
|
Sides Teri Woodwick |
SVP, Vascular Interventions |
|
2022-11-30 |
4 |
D |
$36.13 |
$32,589 |
D/D |
(902) |
19,714 |
|
- |
|
Bedoya Jose H |
Director |
|
2022-11-28 |
4 |
S |
$34.89 |
$152,321 |
D/D |
(4,366) |
24,192 |
|
35% |
|
Bedoya Jose H |
Director |
|
2022-11-28 |
4 |
OE |
$20.18 |
$88,106 |
D/D |
4,366 |
28,558 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2022-11-25 |
4 |
D |
$36.02 |
$78,235 |
D/D |
(2,172) |
153,115 |
|
- |
|
Arens Timothy J. |
Chief Financial Officer |
|
2022-11-25 |
4 |
D |
$36.02 |
$19,559 |
D/D |
(543) |
63,901 |
|
- |
|
Stich Joseph J. |
SVP HR and IVD |
|
2022-11-25 |
4 |
D |
$36.02 |
$21,108 |
D/D |
(586) |
50,311 |
|
- |
|
Sides Teri Woodwick |
SVP, Vascular Interventions |
|
2022-11-25 |
4 |
D |
$36.02 |
$13,147 |
D/D |
(365) |
20,616 |
|
- |
|
Olson Charles W |
SVP, Medical Device Coatings |
|
2022-11-25 |
4 |
D |
$36.02 |
$16,965 |
D/D |
(471) |
41,903 |
|
- |
|
Manders John D. |
Corporate Controller |
|
2022-11-25 |
4 |
D |
$36.02 |
$2,197 |
D/D |
(61) |
4,956 |
|
- |
|
Dantzker David |
Director |
|
2022-11-14 |
4 |
S |
$33.00 |
$91,507 |
D/D |
(2,773) |
34,178 |
|
36% |
|
Dantzker David |
Director |
|
2022-11-14 |
4 |
OE |
$20.18 |
$88,106 |
D/D |
4,366 |
36,951 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2022-11-11 |
4 |
S |
$33.48 |
$91,511 |
D/D |
(2,733) |
30,179 |
|
43% |
|
Kalich Ronald B Sr |
Director |
|
2022-11-11 |
4 |
OE |
$20.18 |
$88,106 |
D/D |
4,366 |
32,912 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2022-09-30 |
4 |
A |
$30.40 |
$17,845 |
D/D |
587 |
28,546 |
|
- |
|
Stich Joseph J. |
SVP HR and IVD |
|
2022-07-19 |
4 |
D |
$36.73 |
$565,128 |
D/D |
(15,386) |
50,596 |
|
- |
|
Stich Joseph J. |
SVP HR and IVD |
|
2022-07-19 |
4 |
OE |
$20.25 |
$403,522 |
D/D |
19,927 |
65,766 |
|
- |
|
Kalich Ronald B Sr |
Director |
|
2022-06-30 |
4 |
A |
$37.23 |
$17,870 |
D/D |
480 |
27,959 |
|
- |
|
Arens Timothy J. |
Chief Financial Officer |
|
2022-05-13 |
4 |
D |
$35.91 |
$5,422 |
D/D |
(151) |
64,444 |
|
- |
|
Weber Gordon S. |
Sr. VP of Legal, GC and Sec. |
|
2022-05-12 |
4 |
D |
$34.33 |
$11,638 |
D/D |
(339) |
11,142 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2022-04-01 |
4 |
AS |
$44.97 |
$179,954 |
D/D |
(4,000) |
155,041 |
|
-17% |
|
Kalich Ronald B Sr |
Director |
|
2022-03-31 |
4 |
A |
$45.33 |
$17,860 |
D/D |
394 |
27,479 |
|
- |
|
Knight Susan E |
Director |
|
2022-02-28 |
4 |
S |
$44.97 |
$196,332 |
D/D |
(4,366) |
30,196 |
|
18% |
|
573 Records found
|
|
Page 3 of 23 |
|
|